Autres langues

10/07 France's Winfarm Signs EUR5 Million Revolver
09/07 WINFARM Secures EUR 5 Million Revolving Credit Facility to Finance Growth of VITAL CONCEPT
09/07 WINFARM secures a €5 million revolving credit facility (RCF) to finance the growth of VITAL CONCEPT
30/04 WINFARM : Q1 2026 revenue.
30/04 WINFARM Société anonyme Reports Unaudited Consolidated Revenue Results for the First Quarter of 2026
31/03 WINFARM reports a strong improvement in its 2025 full-year results.
31/03 WINFARM Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025
29/01 WINFARM Announces Unaudited Consolidated Revenue for the Fourth Quarter and Full-Year 2025
29/01 WINFARM : Growth of 9.2% in Q4 2025. 2025 revenue of €146.2m, up 6.1%.
29/01 WINFARM : Growth of +9.2% in Q4 2025. 2025 revenue of €146.2m, up +6.1%.
05/11 WINFARM : Revenue growth of +5.1% to 30 September 2025.
05/11 WINFARM Confirms Earnings Guidance for the Full Year 2025
05/11 WINFARM Announces Unaudited Consolidated Revenue Results for the Third Quarter and First Nine Months Ended September 30, 2025
02/10/25 WINFARM Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025
02/10/25 Winfarm Société Anonyme Provides Earning Guidance for the Full Year 2025 and Fiscal Year 2027
02/10/25 Very sharp increase in EBITDA, cash generation and debt reduction in H1 2025
03/09/25 Revenue growth of 6.4% in H1 2025
03/09/25 Revenue growth of 6.4% in H1 2025
03/09/25 WINFARM Société Anonyme Reports Unaudited Revenue Results for Second Quarter and First Half Year of 2025
30/04/25 The stock market has just gained 15% but remains in the fog
29/04/25 WINFARM : Ongoing sales momentum in Q1 2025 with +7.9% growth.
31/03/25 WINFARM Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024
31/03/25 WINFARM : 2024 full-year results and 2025 outlook.
30/01/25 WINFARM Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024
30/01/25 WINFARM : Revenue up +4.6% in Q4 2024.
Aucun résultat pour cette recherche